U.S. FDA gives clearance to market for bone void filler based on nanostructured synthetic bone replacement

September 08, 2008 | Analyst Insight

Pioneer Surgical Technology (PST) recently announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market FortrOss, a bone graft substitute. PST's approval is a...